TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ZHEJIANG YONGTAI

CardiovascularInfectious DiseaseGastroenterology
Generics

ZHEJIANG YONGTAI is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.

2019
Since
4
Drugs
-
Trials
268
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

GABAPENTIN 2026-02-24
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
GABAPENTIN 2026-01-29
Labeling
GABAPENTIN 2026-01-29
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 40%
2 drugs
Infectious Disease 40%
2 drugs
Gastroenterology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease